Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.
about
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tractAvian influenza: virology, diagnosis and surveillance.The development of an AIDS mucosal vaccine.Preliminary in vivo efficacy studies of a recombinant rhesus anti-alpha(4)beta(7) monoclonal antibody.Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239Homing in on the cellular immune response to HSV-2 in humans.Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challengeInvB is a type III secretion-associated chaperone for the Salmonella enterica effector protein SopE.Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.Enhancement of recombinant adenovirus vaccine-induced primary but not secondary systemic and mucosal immune responses by all-trans retinoic acid.In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.Evaluation of a Salmonella vectored vaccine expressing Mycobacterium avium subsp. paratuberculosis antigens against challenge in a goat modelProtective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.Repressive effect of primary virus replication on superinfection correlated with gut-derived central memory CD4(+) T cells in SHIV-infected Chinese rhesus macaquesOptimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development.A DNA prime-oral Listeria boost vaccine in rhesus macaques induces a SIV-specific CD8 T cell mucosal response characterized by high levels of alpha4beta7 integrin and an effector memory phenotype.Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeysVaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus.Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virusLive attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.Mucosal AIDS vaccines: current status and future directions.A call for replicating vector prime-protein boost strategies in HIV vaccine design.Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination.Enteric pathogens as vaccine vectors for foreign antigen deliveryEnhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques.HIV vaccine design: insights from live attenuated SIV vaccines.Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy.Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery.An effective vaccination approach augments anti-HIV systemic and vaginal immunity in mice with decreased HIV-1 susceptible α4β7high CD4+ T cells.Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques.Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting.Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: potential application in vaccine and therapeutical developments.Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks
P2860
Q22242965-4DBBDBE9-7DC1-4C59-9903-B16DE829B9C4Q30353483-F79EA5FF-1B78-43BB-A999-FC6332AC82FCQ30408103-2F1AF9B1-7979-49D0-AFD4-1653A36075ECQ30491140-14A13864-F8C4-48AB-AD01-DAF61107C37AQ33843131-FC8A3BB7-1662-43F9-8D25-6286F15B73C0Q34081670-39CD93FB-A561-44C2-A06C-DF39870D8433Q34099837-5D82E93A-F351-4EB8-8D9C-F5F8226CA22FQ34178259-01908C04-485A-40EA-A118-34D23AEE4B27Q34232626-4EF00968-EFD9-49D9-A285-7E4CCA733F05Q34357503-5D9CF659-3CD7-4E8F-A8E9-4E3603C77194Q34448460-19AD83AE-9AF5-43BF-BB78-9A07CA3EE18EQ34691545-184A8F91-FC78-481F-BAD3-E8531AE67913Q34946514-D0BC3AE3-A85D-4F76-84CE-306417A63A8CQ34975686-712131E4-8BA8-4866-9FA3-AC27B373315CQ34983902-1F58C589-5771-480C-8F4D-D261FED47365Q35073979-960308C1-A9C3-42AA-AC6E-4A7F1D5B1F98Q35128581-02DEBAF8-F9E9-4300-88F5-BF54BB227A4DQ35363320-DDE14E6A-8509-4DC5-884A-F90325C11502Q35531553-A8A838B5-5A93-4F10-8EF1-31013436ECEAQ35675044-935C4376-68C0-47AE-98D1-62F32D1AB0FFQ35689514-D83422B7-6898-46D4-83E6-4C91A7056B5AQ35851782-307FB804-BDA4-4197-AEF9-FD2C778576A1Q35851801-830D6059-3E69-4089-A3A4-E46C928A74BFQ35857708-52BC6E82-F301-4AF8-9931-72FFEF6F54A2Q35896020-B2492B4A-9EEA-41B9-AAA1-31B247F1BB5DQ36054037-0916B763-F903-416C-93F0-C33FAE6EBF8AQ36343536-3563314E-90EF-44A8-818D-A1BD776662B5Q36498186-97796858-0776-4890-A9FF-33117126DDADQ36663607-88A6D5BC-CE23-4B02-BC8E-C1AAAD2E2E0BQ36837160-28EDFF60-954D-44F1-935F-78059B6EEB67Q36883886-46999D9A-EF68-4209-83AB-59943746C1FFQ36954239-4B91A851-DFB8-48A0-B8EA-1081CF830A46Q36957667-33BA6A5C-319E-4A10-B14B-9D402A528A80Q37030417-C458CAA4-E758-4B15-B70C-BDC761A8B97EQ37256687-B1F6C1B0-794D-481E-A775-9839E6818529Q37511451-0EA791AD-6CD8-4690-ACFE-C753890CC994Q37590335-12368DF6-046E-44A8-A89C-740526A61645Q37596422-A08DF857-45C1-48FA-B6A0-3E74105756DBQ37602699-26BB0DDC-47AC-4EBA-8040-35631EB789C0Q37821773-BB6BBA64-F98A-4F3F-9DF4-D221E059F1A7
P2860
Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mucosal priming of simian immu ...... etion antigen delivery system.
@ast
Mucosal priming of simian immu ...... etion antigen delivery system.
@en
Mucosal priming of simian immu ...... etion antigen delivery system.
@nl
type
label
Mucosal priming of simian immu ...... etion antigen delivery system.
@ast
Mucosal priming of simian immu ...... etion antigen delivery system.
@en
Mucosal priming of simian immu ...... etion antigen delivery system.
@nl
prefLabel
Mucosal priming of simian immu ...... etion antigen delivery system.
@ast
Mucosal priming of simian immu ...... etion antigen delivery system.
@en
Mucosal priming of simian immu ...... etion antigen delivery system.
@nl
P2093
P2860
P1433
P1476
Mucosal priming of simian immu ...... etion antigen delivery system.
@en
P2093
Brian Harty
David T Evans
Gail P Mazzara
Jacqueline Gillis
Jeffrey D Lifson
Jorge E Galán
Keith G Mansfield
Kuei-Chin Lin
Li-Mei Chen
R Paul Johnson
P2860
P304
P356
10.1128/JVI.77.4.2400-2409.2003
P407
P577
2003-02-01T00:00:00Z